Skip to main navigation
Codiak Biosciences

Investor Relations - Top Nav

  • Our Science

    Our Science

    Through our proprietary engEx™ Platform, we are harnessing the power of nature’s intercellular communication system to engineer a new class of medicines, exosome therapeutics.

    • Exosomes Explained
    • engEx™ Platform
    • Targeted Administration
    • Publications & Presentations
  • Manufacturing
  • Pipeline & Programs

    Pipeline & Programs

    We are utilizing our engEx™ Platform to build a broad pipeline of therapeutic candidates that we believe can have a transformative impact on the treatment of a broad spectrum of diseases, with an initial focus on oncology and neurology.

    • Pipeline
    • exoSTING™
    • exoIL-12™
    • exoASO-STAT6™
  • About Us

    About Us

    At Codiak, we are working to create a major shift in the development of tomorrow’s medicines through scientific ambition, remarkable ingenuity and determined passion for improving patients’ lives.

    • Our Mission
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Careers
  • Investors & Media

    Investors & Media

    Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines.

    • Overview
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • Investor Resources

Corporate Governance

Corporate Governance menu

  • Documents and Charters
  • Committee Composition
Governance Documents
Corporate Governance Guidelines 132 KB
Code of Conduct 245.7 KB
Committee Charters
Compensation Committee Charter 144.9 KB
Nominating and Corporate Governance Committee Charter 100.7 KB
Audit Committee Charter 117.3 KB

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Karen Bernstein Compensation Committee
Charles Cooney Audit Committee Nominating and Corporate Governance Committee
Anne-Virginie Eggimann Nominating and Corporate Governance Committee
Steven Gillis Compensation Committee
Jason Haddock Audit Committee
Theo Melas-Kyriazi Audit Committee Nominating and Corporate Governance Committee
Lini Pandite Compensation Committee
= Chairperson = Member

lnk Leadership Team

Meet our Leadership Team

Join our team of experts working at the forefront of advancing engineered exosomes. Explore Careers

© 2023 All Rights Reserved.

Footer Links

  • Contact
  • Privacy Policy
  • Terms of Use
LinkedIn Twitter